MedTrace Logo

Direct Discharge of Patients With Upper Gastrointestinal Bleeding From the Emergency Department After Endoscopy

NCT03337256 · Status: SUSPENDED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 762

Last updated 2020-04-09

No results posted yet for this study

Summary

Acute upper gastrointestinal bleeding (UGIB) is a common cause for attendance to the Emergency Department with a wide range of clinical severity, ranging from insignificant to life-threatening. While there is robust data to support the benefit of upper endoscopy within 24 hours of admission, the implementation of early upper endoscopy while patients are still in the emergency room has not been widely accepted due to lack of added benefit in terms of patient outcome such as mortality and re-bleeding rate. However, the use of upper endoscopy in the emergency room with the purpose of facilitating early discharge of low risk patients with upper gastrointestinal bleeding has not been studied.

Conditions

  • Upper Gastrointestinal Bleeding

Interventions

DIAGNOSTIC_TEST

GI bleeding score

Risk factor Score component value Age (years) 15-29 -2 30-44 -1.5 45-59 0 60-74 1.5 * 75 2.5 Haemoglobin(g/L) * 10.0 0 \<9.9 2 Systolic blood pressure (mmHg) * 110 0 90-109 1.5 \<90 2.5 Pulse (beats per min) \<100 0 * 100 1.5 Creatinine (mmol/L) \<200 0 * 200 3.5 Number of blood transfusion 0 0 1 1.5 * 2 2 Presenting symptom Melaena -1.5 Drug treatment Acid blcoking drug 1.5 anticoagulant 3 Endoscopy findings Clean-based ulcer -2 SRH or blood in stomach 4 Varices 5

Sponsors & Collaborators

  • Chinese University of Hong Kong

    lead OTHER

Principal Investigators

  • Aric Josun Hui, MD · Chinese University of Hong Kong

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-01
Primary Completion
2025-08-31
Completion
2026-02-28

Countries

  • Hong Kong

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03337256 on ClinicalTrials.gov